Related Experiment Videos
Management of type 1 diabetes
1Chino Medical Group, Diabetes and Headache Intervention Center, Chino, CA 91710, USA. jungermd@aol.com
Primary Care
|December 7, 2007
Summary
Type 1 diabetes management requires daily tools for insulin deficiency. Patients need basal and prandial insulin, plus self-adjustment algorithms to achieve optimal A1C safely.
Area of Science:
- Endocrinology
- Metabolic Diseases
- Autoimmune Disorders
Background:
- Type 1 diabetes (T1D) is an autoimmune condition causing insulin deficiency.
- T1D management presents daily challenges distinct from type 2 diabetes.
- Effective tools are crucial for patients to manage their condition.
Purpose of the Study:
- To highlight the essential components of type 1 diabetes management.
- To emphasize the need for patient-empowering tools and algorithms.
- To outline the goals of achieving optimal glycemic control safely.
Main Methods:
- This abstract discusses established principles of insulin therapy in type 1 diabetes.
- It reviews the necessity of basal and prandial insulin regimens.
- It addresses the importance of self-adjustment algorithms for insulin dosing.
Main Results:
- Patients with type 1 diabetes require both basal and prandial insulin.
- Effective management necessitates algorithms for self-adjusting insulin doses.
- Minimizing glycemic variability and avoiding hypoglycemia are key outcomes.
Conclusions:
- Optimal type 1 diabetes management involves precise insulin dosing and self-adjustment.
- The goal is to maintain A1C levels close to normal while ensuring safety.
- Appropriate tools and algorithms empower patients to manage physiologic insulin deficiency syndrome effectively.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:16Insulin: Dosing Regimen and Adverse Effects
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...